Stoller G et al. |
An 11.8 kDa proteolytic fragment of the E. coli trigger factor represents the domain carrying the peptidyl-prolyl cis/trans isomerase activity. |
1996 |
FEBS Lett. |
pmid:8612805
|
Márquez JA and Serrano R |
Multiple transduction pathways regulate the sodium-extrusion gene PMR2/ENA1 during salt stress in yeast. |
1996 |
FEBS Lett. |
pmid:8612770
|
Galat A |
A note on circular-dichroic-constrained prediction of protein secondary structure. |
1996 |
Eur. J. Biochem. |
pmid:8612612
|
Brousse N and Goulet O |
Small bowel transplantation. |
1996 |
BMJ |
pmid:8611766
|
Furth S et al. |
Diabetes as a complication of tacrolimus (FK506) in pediatric renal transplant patients. |
1996 |
Pediatr. Nephrol. |
pmid:8611359
|
Johnson MW et al. |
Hepatitis C viral infection in liver transplantation. |
1996 |
Arch Surg |
pmid:8611094
|
Osowski CL et al. |
Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients. |
1996 |
Transplantation |
pmid:8610430
|
Cacciarelli TV et al. |
Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation. |
1996 |
Transplantation |
pmid:8610416
|
Hariharan S et al. |
Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity. |
1996 |
Transplantation |
pmid:8610411
|
Yanchar NL et al. |
Tacrolimus (FK506)--its effects on intestinal glucose transport. |
1996 |
Transplantation |
pmid:8610392
|
Singh N et al. |
Pulmonary infections in liver transplant recipients receiving tacrolimus. Changing pattern of microbial etiologies. |
1996 |
Transplantation |
pmid:8610349
|
Peters KP et al. |
The automatic search for ligand binding sites in proteins of known three-dimensional structure using only geometric criteria. |
1996 |
J. Mol. Biol. |
pmid:8609611
|
Esquivel CO et al. |
Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients. |
1996 |
Transplantation |
pmid:8607198
|
Busuttil RW et al. |
General guidelines for the use of tacrolimus in adult liver transplant patients. |
1996 |
Transplantation |
pmid:8607197
|
Suzuki S et al. |
Pure red cell aplasia induced by FK506. |
1996 |
Transplantation |
pmid:8607191
|
Greeno EW et al. |
Exchange transfusion the hard way: massive hemolysis following transplantation of bone marrow with minor ABO incompatibility. |
1996 |
Transfusion |
pmid:8607158
|
Fay JW et al. |
FK506 (Tacrolimus) monotherapy for prevention of graft-versus-host disease after histocompatible sibling allogenic bone marrow transplantation. |
1996 |
Blood |
pmid:8605372
|
Murao K et al. |
Immunosuppressant agent FK506 stimulates growth hormone (GH) secretion and gene expression of hypothalamic GH-releasing hormone in the rat. |
1996 |
Endocrinology |
pmid:8603582
|
Vilquin JT et al. |
Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation. |
1996 |
J. Cell Biol. |
pmid:8601607
|
Lake KD and Canafax DM |
Important interactions of drugs with immunosuppressive agents used in transplant recipients. |
1995 |
J. Antimicrob. Chemother. |
pmid:8601538
|
Rifai N et al. |
The role of lipoproteins in the transport and uptake of cyclosporine and dihydro-tacrolimus into HepG2 and JURKAT cell lines. |
1996 |
Clin. Biochem. |
pmid:8601324
|
Gruessner RW et al. |
A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. |
1996 |
Transplantation |
pmid:8600635
|
Inomata Y et al. |
The evolution of immunosuppression with FK506 in pediatric living-related liver transplantation. |
1996 |
Transplantation |
pmid:8600632
|
Beretta L et al. |
Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. |
1996 |
EMBO J. |
pmid:8599949
|
Ma J et al. |
Rectification of skeletal muscle ryanodine receptor mediated by FK506 binding protein. |
1995 |
Biophys. J. |
pmid:8599646
|
Dan Y et al. |
IL-3 augments TCR-mediated responses of type 2 CD4 T cells. |
1996 |
J. Immunol. |
pmid:8598473
|
Hammond TG and Kind CN |
Pancreatic and nephrotoxicity of immunomodulator compounds. |
1995 |
Toxicol. Lett. |
pmid:8597171
|
Taylor PJ et al. |
Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry. |
1996 |
Clin. Chem. |
pmid:8595724
|
Sakane T et al. |
[A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behçet's disease and allied conditions]. |
1995 |
Ryumachi |
pmid:8594659
|
Dhar DK et al. |
FK506 maintains cellular calcium homeostasis in ischemia-reperfusion injury of the canine liver. |
1996 |
J. Surg. Res. |
pmid:8592405
|
Cardenas ME et al. |
Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin. |
1995 |
Curr. Opin. Nephrol. Hypertens. |
pmid:8591053
|
Lohse DL et al. |
Insights derived from the structures of the Ser/Thr phosphatases calcineurin and protein phosphatase 1. |
1995 |
Structure |
pmid:8590008
|
Jusko WJ et al. |
Consensus document: therapeutic monitoring of tacrolimus (FK-506). |
1995 |
Ther Drug Monit |
pmid:8588229
|
McMaster P et al. |
Therapeutic drug monitoring of tacrolimus in clinical transplantation. |
1995 |
Ther Drug Monit |
pmid:8588228
|
Jusko WJ |
Analysis of tacrolimus (FK 506) in relation to therapeutic drug monitoring. |
1995 |
Ther Drug Monit |
pmid:8588227
|
Fung JJ and Starzl TE |
FK506 in solid organ transplantation. |
1995 |
Ther Drug Monit |
pmid:8588226
|
Thomson AW et al. |
Mode of action of tacrolimus (FK506): molecular and cellular mechanisms. |
1995 |
Ther Drug Monit |
pmid:8588225
|
Soldin SJ |
Receptor (immunophilin-binding) assay for immunosuppressive drugs. |
1995 |
Ther Drug Monit |
pmid:8588223
|
Goodall T et al. |
FK506-induced endothelin release by cultured rat mesangial cells. |
1995 |
J. Cardiovasc. Pharmacol. |
pmid:8587453
|
Takeda Y et al. |
Effect of FK 506 on the expression of endothelin receptor mRNA in the vasculature. |
1995 |
J. Cardiovasc. Pharmacol. |
pmid:8587392
|
Büttemeyer R et al. |
Peripheral nerve allograft transplantation with FK506: functional, histological, and immunological results before and after discontinuation of immunosuppression. |
1995 |
Ann Plast Surg |
pmid:8585683
|
Gonschior AK et al. |
Simplified high-performance liquid chromatography-mass spectrometry assay for measurement of tacrolimus and its metabolites and cross-validation with microparticle enzyme immunoassay. |
1995 |
Ther Drug Monit |
pmid:8585114
|
Hemenway CS et al. |
vph6 mutants of Saccharomyces cerevisiae require calcineurin for growth and are defective in vacuolar H(+)-ATPase assembly. |
1995 |
Genetics |
pmid:8582630
|
Sekigawa I et al. |
Inhibitory effect of the immunosuppressant FK506 on apoptotic cell death induced by HIV-1 gp120. |
1995 |
J. Clin. Immunol. |
pmid:8576317
|
Wesselborg S et al. |
Identification of a physical interaction between calcineurin and nuclear factor of activated T cells (NFATp). |
1996 |
J. Biol. Chem. |
pmid:8576111
|
Sano T et al. |
FK506 and cyclosporin A inhibit granulocyte/macrophage colony-stimulating factor production by mononuclear cells in asthma. |
1995 |
Eur. Respir. J. |
pmid:8575571
|
Vilquin JT et al. |
FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. |
1995 |
Hum. Gene Ther. |
pmid:8573612
|
Castillo Lugo JA |
Clinical and experimental immunosuppression. |
1995 May-Jun |
Bol Asoc Med P R |
pmid:8573248
|
Charters AR et al. |
Developmental expression of FK506 binding proteins and calcineurin in rat brain. |
1995 |
Biochem. Soc. Trans. |
pmid:8566310
|
Tanida I et al. |
Yeast Cls2p/Csg2p localized on the endoplasmic reticulum membrane regulates a non-exchangeable intracellular Ca2+ pool cooperatively with calcineurin. |
1996 |
FEBS Lett. |
pmid:8566225
|
Itoh S and Navia MA |
Structure comparison of native and mutant human recombinant FKBP12 complexes with the immunosuppressant drug FK506 (tacrolimus). |
1995 |
Protein Sci. |
pmid:8563622
|
Stillman IE et al. |
FK506 nephrotoxicity: morphologic and physiologic characterization of a rat model. |
1995 |
Lab. Invest. |
pmid:8558840
|
Ryffel B et al. |
Interleukin-2 receptor (CD25) upregulation on human T-lymphocytes: sensitivity to immunosuppressants is defined by the mode of T-lymphocyte activation. |
1995 |
Immunopharmacology |
pmid:8557519
|
Fukunaga T et al. |
Osteogenesis in xenogeneic bone transplantation, using an immunosuppressant. Rabbit-rat experiments. |
1995 |
Acta Orthop Scand |
pmid:8553828
|
Delaney CP et al. |
Allogeneic hematolymphoid microchimerism and prevention of autoimmune disease in the rat. A relationship between allo- and autoimmunity. |
1996 |
J. Clin. Invest. |
pmid:8550837
|
Koch K et al. |
CP-123,369: a potent, orally active immunosuppressive agent. |
1995 |
Inflamm. Res. |
pmid:8548388
|
Gharpure VS et al. |
Thrombotic thrombocytopenic purpura associated with FK506 following bone marrow transplantation. |
1995 |
Bone Marrow Transplant. |
pmid:8547871
|
Aoyama H et al. |
Successful treatment of resistant facial lesions of atopic dermatitis with 0.1% FK506 ointment. |
1995 |
Br. J. Dermatol. |
pmid:8547017
|
Fryer JP et al. |
Bacterial translocation in a large-animal model of small-bowel transplantation. Portal vs systemic venous drainage and the effect of tacrolimus immunosuppression. |
1996 |
Arch Surg |
pmid:8546583
|
Shirakata Y et al. |
Inhibitory effect of plasma FKBP12 on immunosuppressive activity of FK506. |
1995 |
Transplantation |
pmid:8545894
|
Gjertson DW et al. |
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. |
1995 |
Transplantation |
pmid:8545861
|
Andoh TF et al. |
Functional and structural characteristics of experimental FK 506 nephrotoxicity. |
1995 |
Clin. Exp. Pharmacol. Physiol. |
pmid:8542679
|
Jonas S et al. |
Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial. |
1995 |
Clin Transplant |
pmid:8541635
|
Bersztel A et al. |
Deoxyspergualin is synergistic with cyclosporin A, but not with FK506 in a rat heart allograft transplantation model. |
1995 |
Transplant. Proc. |
pmid:8540095
|
Felldin M et al. |
Rescue therapy with Tacrolimus (FK506) in renal transplant recipients--a multicenter analysis. |
1995 |
Transplant. Proc. |
pmid:8540032
|
Tai J et al. |
In vivo function of pig islet xenografts in immunosuppressed diabetic mice. |
1995 |
Transplant. Proc. |
pmid:8539968
|
Wennberg L et al. |
Immunosuppression with leflunomide and cyclosporine prevents pig-to-rat islet xenograft rejection. |
1995 |
Transplant. Proc. |
pmid:8539967
|
Burke GW et al. |
The use of FK506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression. |
1995 |
Transplant. Proc. |
pmid:8539874
|
Burke GW et al. |
Use of FK 506 in simultaneous pancreas/kidney transplantation: lack of impairment of glycemic or lipid metabolism. |
1995 |
Transplant. Proc. |
pmid:8539872
|
Tesi RJ et al. |
Conversion of pancreas transplants to FK 506 from CsA. |
1995 |
Transplant. Proc. |
pmid:8539828
|
Swanson C et al. |
FK 506-based immunosuppression in clinical pancreas transplantation. |
1995 |
Transplant. Proc. |
pmid:8539827
|
Stratta RJ et al. |
Preliminary experience with FK 506 in pancreas transplant recipients. |
1995 |
Transplant. Proc. |
pmid:8539823
|
Henley SE et al. |
Lipids following pancreas transplantation in recipients receiving FK 506. |
1995 |
Transplant. Proc. |
pmid:8539809
|
Hariharan S et al. |
Conversion from cyclosporine to tacrolimus after pancreas transplantation. |
1995 |
Transplant. Proc. |
pmid:8539799
|
Groth CG |
Immunosuppressive regimens of tomorrow. |
1995 |
Transplant. Proc. |
pmid:8539797
|
Faerman CH and Karplus PA |
Consensus preferred hydration sites in six FKBP12-drug complexes. |
1995 |
Proteins |
pmid:8539241
|
Eckert B et al. |
Calcium-mobilizing insulin secretagogues stimulate transcription that is directed by the cyclic adenosine 3',5'-monophosphate/calcium response element in a pancreatic islet beta-cell line. |
1996 |
Endocrinology |
pmid:8536617
|
Ihara H et al. |
Intra- and interindividual variation in the pharmacokinetics of tacrolimus (FK506) in kidney transplant recipients--importance of trough level as a practical indicator. |
1995 |
Int. J. Urol. |
pmid:8536129
|
Orengo CA et al. |
Structural similarity between the pleckstrin homology domain and verotoxin: the problem of measuring and evaluating structural similarity. |
1995 |
Protein Sci. |
pmid:8535234
|
Ockenfels HM et al. |
Tyrosine phosphorylation in psoriatic T cells is modulated by drugs that induce or improve psoriasis. |
1995 |
Dermatology (Basel) |
pmid:8534940
|
Zhu X et al. |
Enhancing and suppressive effects of immunosuppressants cyclosporin A, FK506, and KM2210 on the colony formation of murine bone marrow cells. |
1995 |
Ann. Hematol. |
pmid:8534762
|
Kaplan A et al. |
The effects of cyclosporin A and FK506 on proliferation and IL-8 production of cultured human keratinocytes. |
1995 |
J. Dermatol. Sci. |
pmid:8534611
|
Mugiya S et al. |
Renal blood flow, fibrinolysis, and platelet aggregation following tacrolimus (FK 506) treatment in rats. |
1995 |
Thromb. Res. |
pmid:8533130
|
Büttemeyer R et al. |
Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine. |
1996 |
Plast. Reconstr. Surg. |
pmid:8532772
|
Tamura K |
FK506: mechanism of immunosuppression and adverse-effects. |
1995 |
J Toxicol Sci |
pmid:8531246
|
Arreaza G et al. |
Expression of intercellular adhesion molecule-1 on human thyroid cells from patients with autoimmune thyroid disease: study of thyroid xenografts in nude and severe combined immunodeficient mice and treatment with FK-506. |
1995 |
J. Clin. Endocrinol. Metab. |
pmid:8530625
|
Ku YM et al. |
Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection. |
1995 |
Am J Health Syst Pharm |
pmid:8528874
|
Lionetti P et al. |
Mucosal adaptation and destruction in response to lamina propria T cell activation in explants of human fetal intestine. |
1995 |
Adv. Exp. Med. Biol. |
pmid:8525974
|
Kissinger CR et al. |
Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex. |
1995 |
Nature |
pmid:8524402
|
Cameron AM et al. |
Calcineurin associated with the inositol 1,4,5-trisphosphate receptor-FKBP12 complex modulates Ca2+ flux. |
1995 |
Cell |
pmid:8521476
|
Krentz AJ et al. |
Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients. |
1993 |
Diabetes |
pmid:7694879
|
Lhoëst G et al. |
Isolation and identification of a novel isomerized epoxide metabolite of FK-506 from erythromycin-induced rabbit liver microsomes. |
1993 Sep-Oct |
Drug Metab. Dispos. |
pmid:7694828
|
Zuany-Amorim C et al. |
Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice. |
1993 |
Br. J. Pharmacol. |
pmid:7694762
|
White DJ |
Immunosuppression for heart transplantation. |
1993 |
Br. J. Biomed. Sci. |
pmid:7694717
|
Bierer BE et al. |
Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. |
1993 |
Curr. Opin. Immunol. |
pmid:7694595
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
Jusko WJ and Kobayashi M |
Therapeutic monitoring of tacrolimus (FK 506) |
1993 |
Ther Drug Monit |
pmid:7694395
|
Travis J |
Making molecular matches in the cell. |
1993 |
Science |
pmid:7694368
|
Spencer DM et al. |
Controlling signal transduction with synthetic ligands. |
1993 |
Science |
pmid:7694365
|
Dawson TM et al. |
Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. |
1993 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:7694293
|